Columnist Ben Hofmeister knows that living his best life is his mission, so he tries to put his multiple sclerosis in proper context.

Biostate AI and the Accelerated Cure Project will to develop AI models to predict multiple sclerosis progression and ...

The ENHANCE Phase 3b clinical trial is evaluating the safety and efficacy of a modified treatment regimen of Briumvi for ...

MS patients in the U.S. with Medicaid coverage have worse disease outcomes compared with those who have private insurance, a ...

Over five years, relapsing-remitting multiple sclerosis patients in France taking Tysabri have adopted more at-home dosing, a review found.

The CAR T-cell therapy KYV-101 is safe, and showed preliminary signs of efficacy in patients with progressive forms of MS in ...

Frexalimab was well tolerated and maintained disease control over two years in adults with relapsing MS in an open-label ...

Balance issues with MS make it difficult for columnist Leigh Anne Nelson to navigate stairs and aisles at stadium events.

Tolebrutinib was found to delay disability progression in people with nonrelapsing secondary progressive MS in a Phase 3 ...

Treatment with CNM-Au8 led to clinical improvements in relapsing-remitting MS patients that linked to signs of nerve cell ...

Pain is challenging, but it doesn't have to define your life. Episode 2 of Get Tough on Multiple Sclerosis offers practical ...